Cachet Pharmaceutical Co Ltd (002462) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Cachet Pharmaceutical Co Ltd (002462) has a cash flow conversion efficiency ratio of 0.078x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥459.95 Million ≈ $67.31 Million USD) by net assets (CN¥5.88 Billion ≈ $859.82 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cachet Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2007–2025)
This chart illustrates how Cachet Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read total liabilities of Cachet Pharmaceutical Co Ltd for a breakdown of total debt and financial obligations.
Cachet Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Cachet Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
EPC Groupe
PA:EXPL
|
0.235x |
|
Hangzhou Zhengqiang Corporation Limited
SHE:301119
|
0.047x |
|
Merlin, Inc.
NASDAQ:MRLN
|
0.025x |
|
Royce Micro Cap Closed Fund
NYSE:RMT
|
-0.003x |
|
H&R Century Union Corp
SHE:000892
|
-0.020x |
|
First Tracks Biotherapeutics
NASDAQ:TRAX
|
N/A |
|
Fuchun Technology Co Ltd
SHE:300299
|
-0.037x |
|
TPI POLENE POWER
BK:TPIPP-R
|
0.008x |
Annual Cash Flow Conversion Efficiency for Cachet Pharmaceutical Co Ltd (2007–2025)
The table below shows the annual cash flow conversion efficiency of Cachet Pharmaceutical Co Ltd from 2007 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of Cachet Pharmaceutical Co Ltd.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥5.88 Billion ≈ $859.82 Million |
CN¥1.39 Billion ≈ $203.72 Million |
0.237x | +696.75% |
| 2024-12-31 | CN¥6.06 Billion ≈ $887.48 Million |
CN¥180.36 Million ≈ $26.39 Million |
0.030x | -88.65% |
| 2023-12-31 | CN¥6.09 Billion ≈ $891.38 Million |
CN¥1.60 Billion ≈ $233.46 Million |
0.262x | +1048.89% |
| 2022-12-31 | CN¥5.92 Billion ≈ $866.52 Million |
CN¥-163.45 Million ≈ $-23.92 Million |
-0.028x | -117.10% |
| 2021-12-31 | CN¥5.66 Billion ≈ $827.73 Million |
CN¥913.13 Million ≈ $133.62 Million |
0.161x | -22.91% |
| 2020-12-31 | CN¥5.32 Billion ≈ $779.07 Million |
CN¥1.11 Billion ≈ $163.14 Million |
0.209x | +251.69% |
| 2019-12-31 | CN¥4.92 Billion ≈ $720.37 Million |
CN¥293.11 Million ≈ $42.89 Million |
0.060x | +176.18% |
| 2018-12-31 | CN¥3.73 Billion ≈ $546.21 Million |
CN¥-291.76 Million ≈ $-42.69 Million |
-0.078x | +33.19% |
| 2017-12-31 | CN¥3.20 Billion ≈ $467.85 Million |
CN¥-374.04 Million ≈ $-54.73 Million |
-0.117x | -395.26% |
| 2016-12-31 | CN¥2.94 Billion ≈ $429.52 Million |
CN¥116.30 Million ≈ $17.02 Million |
0.040x | +128.12% |
| 2015-12-31 | CN¥2.20 Billion ≈ $322.23 Million |
CN¥-310.34 Million ≈ $-45.41 Million |
-0.141x | +69.13% |
| 2014-12-31 | CN¥1.67 Billion ≈ $245.05 Million |
CN¥-764.46 Million ≈ $-111.86 Million |
-0.457x | -90.46% |
| 2013-12-31 | CN¥1.30 Billion ≈ $190.72 Million |
CN¥-312.39 Million ≈ $-45.71 Million |
-0.240x | -632.63% |
| 2012-12-31 | CN¥1.13 Billion ≈ $165.01 Million |
CN¥-36.89 Million ≈ $-5.40 Million |
-0.033x | -173.44% |
| 2011-12-31 | CN¥1.09 Billion ≈ $159.55 Million |
CN¥48.57 Million ≈ $7.11 Million |
0.045x | +192.02% |
| 2010-12-31 | CN¥1.02 Billion ≈ $149.95 Million |
CN¥-49.61 Million ≈ $-7.26 Million |
-0.048x | -154.47% |
| 2009-12-31 | CN¥563.92 Million ≈ $82.52 Million |
CN¥50.12 Million ≈ $7.33 Million |
0.089x | -23.01% |
| 2008-12-31 | CN¥475.03 Million ≈ $69.51 Million |
CN¥54.83 Million ≈ $8.02 Million |
0.115x | +203.32% |
| 2007-12-31 | CN¥577.44 Million ≈ $84.50 Million |
CN¥-64.52 Million ≈ $-9.44 Million |
-0.112x | -- |
About Cachet Pharmaceutical Co Ltd
Cachet Pharmaceutical Co., Ltd. engages in the wholesale, retail, and logistics of pharmaceutical products in China. The company also offers medical drugs, medical devices, e-commerce products, and warehousing logistics services. It sells its products through online and offline channels. The company was founded in 1997 and is headquartered in Beijing, China.